State Board of Administration of Florida Retirement System’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-11,215
Closed -$56K 2438
2021
Q1
$56K Hold
11,215
﹤0.01% 2341
2020
Q4
$142K Hold
11,215
﹤0.01% 2237
2020
Q3
$110K Hold
11,215
﹤0.01% 2207
2020
Q2
$112K Buy
11,215
+558
+5% +$5.35K ﹤0.01% 2207
2020
Q1
$94K Hold
10,657
﹤0.01% 2073
2019
Q4
$98K Hold
10,657
﹤0.01% 2209
2019
Q3
$63K Hold
10,657
﹤0.01% 2237
2019
Q2
$128K Buy
+10,657
New +$115K ﹤0.01% 2229

Other funds holding CNCE

State Board of Administration of Florida Retirement System's CNCE Position: Q2 2021 in Review

State Board of Administration of Florida Retirement System sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2021, closing a stake of 11,215 shares — an estimated $56K sold.

State Board of Administration of Florida Retirement System first reported a position in CNCE in Q2 2019 and held it in 8 quarters. The position peaked at $142K in Q4 2020. 79 funds tracked by Wall St. Rank hold CNCE as of Q2 2021.

  • State Board of Administration of Florida Retirement System reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 11,215 Concert Pharmaceuticals, Inc. shares in Q2 2021, an estimated $56K.
  • State Board of Administration of Florida Retirement System first reported a position in Concert Pharmaceuticals, Inc. in Q2 2019 and held it in 8 quarters.
  • State Board of Administration of Florida Retirement System's Concert Pharmaceuticals, Inc. position peaked at $142K in Q4 2020.
  • 79 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2021.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2021, filed 10 Aug 2021.